DSG1 and Alzheimer disease: Research suggests that IL-4 and IL-13 downregulate DSG1 expression in both the cultured human keratinocyte (HaCaT) cell line and the skin of people with AD, which may contribute to the impaired skin barrier observed in individuals with AD [51].